NCT02123927View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of TAK-438 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Ascending Single Dose Study
Interventions
DRUG

TAK-438

TAK-438 tablets

DRUG

Placebo

TAK-438 placebo-matching tablets

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY